Original articles
LAN Shishi, HUANG Ye, WANG Chunhui, ZHANG Hongxing
Objective To investigate the feasibility of using the cell-free DNA (cfDNA) carrying tissue-specific mutations as biomarkers for assessing the severity of exercise-induced tissue injury. Methods Based on a public gene expression database, ten tissue-specific and highly-expressed genes were selected for each of ten different human tissues. A total of 34 young healthy volunteers were recruited, and their peripheral blood samples were collected after running 5 km per day for one week. Genomic DNA from leukocytes, plasma exosomal RNA, and plasma cfDNA were extracted and subjected to high-throughput sequencing respectively. Tissue-specific somatic mutations in plasma exosomal RNA were identified, and the relationship between cfDNA carrying these mutations and traditional protein biomarkers was analyzed. Results Tissue-specific cfDNA mutations related to five tissues (myocardium, skeletal muscle, intestine, stomach, and kidney) were detected in more than five volunteers. The correlation coefficients between total plasma cfDNA levels and the levels of tissue-specific protein biomarkers associated with these five tissues were less than 0.3 (n=34, r=-0.51-0.28, P=0.0022-0.65). Notably, for each specific tissue, the levels of tissue-specific cfDNA mutations were positively correlated with the corresponding protein biomarker levels, and correlation coefficients were over 0.8 (n=7-13, r=0.81-0.92, P=9.0× 10-4-0.020). Conclusion Tissue-specific cfDNA mutations may serve as novel potential biomarkers for non-invasive evaluation of exercise-related tissue injury.